Geographic Analysis of Diagnosis of Attention-Deficit/Hyperactivity Disorder in Children: Eastern Wisconsin,USA

Abstract

Objective:

To perform a novel geographic analysis of Attention-Deficit/Hyperactivity Disorder (ADHD) diagnosis in Midwest United States.

Method:

Primary care children age 5–17 with ADHD diagnosis (N = 6833; 13.5%) were compared to those receiving well child care without ADHD diagnosis (N = 43,630) in a Wisconsin integrated medical system. Street addresses, demographic, and block group level U.S. Census 2000 data were mapped and analyzed using ArcGIS, CrimeStat III, and SaTScan. Lead levels from a State database were linked to 2,837 subjects. Univariate analysis was done by chi-square test or Mann-Whitney U test, multivariate analysis by logistic regression.

Results:

ADHD cases were 74% male (p = 0.0001), and more frequently diagnosed in White children (17.3%) than Blacks (10.6%), Hispanics (9.4%), or Asians (3.7%; all p values < 0.001). Overall, male gender, white race, lower block group median household income and population density, and greater distance to nearest park and airport were more predictive of ADHD (p values < 0.001). In urban Milwaukee County (865 cases/10,493 controls) male gender, white race, suburban residence, and younger age were more predictive of ADHD (p values < 0.01). Among children with ADHD diagnosis and linked lifetime lead values, those with a maximum level of 10 μg/dl or more differed significantly from controls (9.3% vs. 5.6%; p = 0.003); elevated lead remained a significant predictor of ADHD diagnosis in multivariate analysis.

Conclusions:

Further studies are needed to determine if geographic distribution of ADHD diagnosis can be partially explained by differential efficiency of referral for diagnosis by school districts, by race/ethnicity, and/or built environment.

Keywords

attention-deficit/hyperactivity disorder ADHD lead poisoning geographic information systems children prevalence urban rural

Get full access to this article

View all access options for this article.

References

Rappley

. Attention-deficit/hyperactivity disorder. New England Journal of Medicine 2005; 352: 166–173.

Spencer

Biederman

Mick

. Attention-deficit/hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology. Ambulatory Pediatrics 2007; 7: 73–81.

Visser

Lesesne

. Mental health in the United States: Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder—United States, 2003. MMWR 2005; 54: 842–847.

Guilherme

de Lima

Silva M

Horta

Biederman

Rohde

. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry 2007; 164: 942–948.

Rowland

Lesesne

Abramowitz

. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): A public health view. Mental Retardation and Developmental Disabilities Research Reviews 2002; 8(3): 162–170, DOI: 10.1002/mrdd.10036.

Scahill

Schwab-Stone

. Epidemiology of ADHD in school-age children. Child and Adolescent Psychiatric Clinics of North America 2000; 9: 541–555.

Swanson

Kinsbourne

Nigg

Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychology Review 2007; 17: 39–59, DOI: 10.1007/s11065-007-9019-9.

Biederman

Faraone

. Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237–248.

Braun

Kahn

Froelich

Auinger

Lanphear

. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environmental Health Perspectives 2006; 114: 1904–1909, DOI: 10.1289/ehp.9478.

10.

Banerjee

Middleton

Faraone

. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatrica 2007; 96: 1269–1274, DOI: 10.1111/j.1651-2227.2007.00430.x.

11.

Millichap

. Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics 2008; 121: e358–365, DOI: 10.1542/peds.2007-1332.

12.

Cornelius

Day

. Developmental consequences of prenatal tobacco exposure. Current Opinion in Neurology 2009; 22: 121–125, DOI: 10.1097/WCO. 0b013e328326f6dc.

13.

Percentage of children aged 6–17 years with learning disability (LD) and attention deficit hyperactivity disorder (ADHD), by birthweight—National Health Interview Survey, United States, 2004–2006. MMWR 2008; 57: 947.

14.

Nigg

Knottnerus

Martel

Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control. Biological Psychiatry 2008; 63: 325–331, DOI: 10.1016/j.biopsych.2007.07.013.

15.

Pastor

Reuben

. Racial and ethnic differences in ADHD and LD in young school-age children: Parental reports in the national health interview survey. Public Health Reports 2005; 120(4): 383–392.

16.

Nolan

Gadow

Sprafkin

. Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in school children. Journal of the American Academy of Child and Adolescent Psychiatry 2001; 40: 241–249.

17.

Kuo

Taylor

. A potential natural treatment for attention-deficit/hyperactivity disorder: Evidence from a national study. American Journal of Public Health 2004; 94: 1580–1586.

18.

Timimi

, 33 Coendorsers. A critique of the international consensus statement on ADHD. Clinical and Child Family Psychology Review 2004; 7: 59–63.

19.

Timimi

Taylor

. ADHD is best understood as a cultural construct. British Journal of Psychiatry 2004; 184: 8–9.

20.

Cohen

Morley

. Children, ADHD, and citizenship. Journal of Medicine and Philosophy 2009; 34: 155–180.

21.

Rohde

Szobot

Polanczyk

Schmitz

Martins

Tramontina

. Attention-deficit/hyperactivity disorder in a diverse culture: Do research and clinical findings support the notion of a cultural construct for the disorder? Biological Psychiatry 2005; 57: 1436–1441.

22.

Morley

. The effects of patient characteristics on ADHD diagnosis and treatment: A factorial study of family physicians. BMC Family Practice 2010; 11: 11.

23.

Fremont

Nastasi

Newman

Roizen

. Comfort level of pediatricians and family medicine physicians diagnosing and treating child and adolescent 10. psychiatric disorders. International Journal of Psychiatry in Medicine 2008; 38: 153–168.

24.

Daly

Rasmussen

Agerter

Cha

. Assessment and diagnosis of attention-deficit/hyperactivity disorder by family physicians. Minnesota Medicine 2006; 89: 40–43.

25.

Lanham

. The evaluation of attention deficit/hyperactivity disorder in family medicine residency programs. Southern Medical Journal 2006; 99: 802–805.

26.

Rushton

Fant

Clark

. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics 2004; 114: e23–e28.

27.

Bussing

Zima

Gary

Garvan

. Barriers to detection, help-seeking, and service use for children with ADHD symptoms. Journal of Behavioral Health Services Research 2003; 30: 176–189.

28.

Rappley

Gardiner

Jetton

Houang

. The use of methylphenidate in Michigan. Archives of Pediatric and Adolescent Medicine 1995; 149: 675–679.

29.

Kulldorff

. A spatial scan statistic. Communications in Statistics: Theory and Methods 1997; 26: 1481–1496.

30.

Selden

. Compliance with well-child visit recommendations: Evidence from the Medical Expenditure Panel Survey, 2000–2002. Pediatrics 2006; 118: e1766–e1778, DOI: 10.1542/peds.2006-0286.

31.

Evink

Crouse

Elliott

. Diagnosing childhood attention-deficit/hyperactivity disorder. Do family practitioners and pediatricians make the same call? Minnesota Medicine 2000; 83: 57–62.

32.

Rushton

Felt

Roberts

. Coding of pediatric behavioral and mental disorders. Pediatrics 2002; 110: e8, DOI: 10.1542/peds.110.1.e8.

33.

Kielbasa

Pomerantz

Krohn

Sullivan

. How does clients' method of payment influence diagnostic decisions? Ethics and Behavior 2004; 14: 187–195.

34.

Bussing

Schoenberg

Perwien

. Knowledge and information about ADHD: Evidence of cultural differences among African-American and white parents. Social Science and Medicine 1998; 46: 919–928.

35.

Bussing

Koro-Ljungberg

Gary

Mason

Garvan

. Exploring help-seeking for ADHD symptoms: A mixed-methods approach. Harvard Review of Psychiatry 2005; 13: 85–101.

36.

Bussing

Gary

Mills

Garvan

. Parental explanatory models of ADHD: Gender and cultural variations. Social Psychiatry and Psychiatric Epidemiology 2003; 38: 563–575.

37.

Bussing

Zima

Belin

. Differential access to care for children with ADHD in special education programs. Psychiatric Services 1998; 49: 1226–1229.

38.

Angold

Erkanli

Farmer

Fairbank

Burns

Keeler

Costello

. Psychiatric disorder, impairment, and service use in rural African American and white youth. Archives of General Psychiatry 2002; 59: 893–901.

39.

Vila

Swain

Baumgardner

Halsmer

Remington

Cisler

. Health disparities in Milwaukee by socioeconomic status. Wisconsin Medical Journal 2007; 106: 366–372.

40.

Kendall

Hatton

. Racism as a source of health disparity in families with children with attention deficit hyperactivity disorder. Advances in Nursing Science 2002; 25(2): 22–39.

41.

Evans

. Ethnic differences in ADHD and the mad/bad debate. American Journal of Psychiatry 2004; 161: 932.

42.

Froehlich

Lanphear

Auinger

Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics 2009; 124: e1054–e1063, DOI: 10.1542/peds.2009-0738.

43.

Nigg

. ADHD, lead exposure and prevention: How much lead or how much evidence is needed? Expert Reviews of Neurotherapeutics 2008; 8: 519–521, DOI: 10.1586/14737175.8.4.519.